secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0000914475-24-000229
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine Biosciences launches CRENESSITY for classic CAH at WAC ~$38,333/month
--------------------------------------------------------------------------------

- CRENESSITY commercially available in U.S. for classic CAH (ages 4+); dispensed exclusively via PANTHERx Rare specialty pharmacy.
- Wholesale acquisition cost ~$38,333/30-day supply for adults; ~$19,167 for pediatric patients <20 kg.
- Company expects 90% of patients will have monthly copay of $12 or less through Neurocrine Access Support.
- CAH-trained pharmacists available 24/7 via PANTHERx Rare; free support program for patients and providers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447524000229/0000914475-24-000229-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447524000229/nbix-20241220.htm
  HTML page:      https://secwatch.observer/filing/0000914475-24-000229

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer